Abstract Objective To explore the association between CYP1A1*2A polymorphism and susceptibility to childhood acute lymphoblastic leukemia (ALL) through a Meta analysis. Methods Inclusion and exclusion criteria were formulated and English and Chinese databases (PubMed, OVID Database, CBM, CNKI, and Wanfang Data) were searched comprehensively. The studies (from January 1999 to April 2015) related to the association between CYP1A1*2A polymorphism and susceptibility to childhood ALL were collected. STATA 12.0 Software was applied to perform the Meta analysis for the articles included. Results A total of 12 articles were included for analysis (11 English articles and 1 Chinese article), which involved 3 355 cases in total. The results of the Meta analysis showed a significant association between CYP1A1*2A polymorphism and susceptibility to childhood ALL (allele model:OR=1.31, 95%CI:1.07-1.61;dominant model:OR=1.33, 95%CI:1.13-1.56;codominant model:OR=1.30, 95%CI:1.10-1.54). According to the results of a subgroup analysis based on ethnic origin, an increased risk of childhood ALL was observed in both Asian subgroup (dominant model:OR=1.57, 95%CI:1.19-2.08;codominant model:OR=1.61, 95%CI:1.20-2.17) and the Caucasian subgroup (allele model:OR=1.31, 95%CI:1.04-1.63;dominant model:OR=1.22, 95%CI:1.00-1.49). Conclusions CYP1A1*2A polymorphism may be associated with the genetic susceptibility to childhood ALL.
ZOU Ze-Qiao,YUE Li-Jie,REN Yan-Fei. Association between CYP1A1*2A polymorphism and susceptibility to childhood acute lymphoblastic leukemia:a Meta analysis[J]. CJCP, 2015, 17(10): 1112-1118.
ZOU Ze-Qiao,YUE Li-Jie,REN Yan-Fei. Association between CYP1A1*2A polymorphism and susceptibility to childhood acute lymphoblastic leukemia:a Meta analysis[J]. CJCP, 2015, 17(10): 1112-1118.
Moulik NR, Parveen F, Kumar A, et al. Glutathione-Stransferase polymorphismand and acute lymphoblastic leukemia (ALL) in north Indian children:a case-control study and metaanalysis[J]. J Hum Genet, 2014, 59(9):529-535.
[2]
Li X, Liao Q, Zhang S, et al. Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukaemia (ALL) in Chinese population[J]. Eur J Med Res, 2014, 19(1):5.
[3]
Margulis AV, Pladevall M, Riera-Guardia N, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools:the Newcastle-Ottawa Scale and the RTI item bank[J]. Clin Epidemiol, 2014, 6:359-368.
[4]
Krajinovic M, Labuda D, Richer C, et al. Susceptibility to childhood acute lymphoblastic leukemia:influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms[J]. Blood, 1999, 93(5):1496-1501.
[5]
Balta G, Yuksek N, Ozyurek E, et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia[J]. Am J Hematol, 2003, 73(3):154-160.
Joseph T, Kusumakumary P, Chacko P, et al. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children[J]. Pediatr Blood Cancer, 2004, 43(5):560-567.
[8]
Canalle R, Burim RV, Tone LG, et al. genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia[J]. Environ Mol Mutagen, 2004, 43(2):100-109.
[9]
Clavel J, Bellec S, Rebouissou S, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy[J]. Eur J Cancer Prev, 2005, 14(6):531-540.
[10]
Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, et al. Role of cyp2d6, cyp1a1, cyp2e1, gstt1, and gstm1 genes in the susceptibility to acute leukemias[J]. Am J Hematol, 2006, 81(3):162-170.
[11]
Lee KM, Ward MH, Han S, et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk[J]. Leuk Res, 2009, 33(2):250-258.
[12]
Yamaguti GG, Lourenço GJ, Silveira VS, et al. Increased risk for acute lymphoblastic leukemia in children with cytochrome p450a1 (cyp1a1)-and nad(p)h_quinone oxidoreductase 1 (nqo1)-inherited gene variants[J]. Acta Haematol, 2010, 124(3):182-186.
[13]
Swinney RM, Beuten J, Collier AB 3rd, et al. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20(7):1537-1542.
[14]
Suneetha KJ, Nancy KN, Rajalekshmy KR, et al. Role of glutathione-s-transferase and CYP1A1*2A polymorphisms in the therapy outcome of south Indian acute lymphoblastic leukemia patients[J]. Indian J Med Paediatr Oncol, 2011, 32(1):25-29.
[15]
Agha A, Shabaan H, Abdel-Gawad E, et al. Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt[J]. Leuk Lymphoma, 2014, 55(3):618-623.
[16]
Liu C, Jiang Z, Deng QX, et al. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese[J]. Asian Pac J Cancer Prev, 2014, 15(11):4689-4695.
[17]
Zhan P, Wang Q, Qian Q, et al. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk:an updated meta-analysis and review[J]. J Exp Clin Cancer Res, 2011, 30:99.
[18]
Steffen C, Auclerc MF, Auvrignon A, et al. Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons:a case-control study[J]. Occup Environ Med, 2004, 61(9):773-778.
[19]
Han F, Tan Y, Cui W, et al. Novel insights into etiologies of leukemia:a HuGE review and meta-analysisof CYP1A1 polymorphisms and leukemia risk[J]. Am J Epidemiol, 2013, 178(4):493-507.
[20]
Voso MT, D'Alo' F, Gumiero D, et al. The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia[J]. Haematologica, 2005, 90(7):982-984.
[21]
Krajinovic M, Labuda D, Mathonnet G, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia1[J]. Clin Cancer Res, 2002, 8(3):802-810.
